technology

UBS Strategist Gerry Fowler Identifies Opportunities in US Cyclicals and Pharmaceuticals

24 Haziran 2026Bllomberg

Gerry Fowler, UBS Chief European Equity Strategist, analyzes the recent tech selloff and identifies potential value in US cyclicals and pharmaceuticals. He emphasizes the inevitability of market volatility, suggesting that current market structures contribute to this instability.
Fowler's insights indicate a cautious yet strategic approach to navigating current market conditions.
The discussion comes at a time when markets are experiencing significant fluctuations, particularly in the technology sector. Investors are grappling with the implications of these changes and are seeking guidance on where to allocate resources effectively.
Fowler's perspective sheds light on the underlying dynamics of market behavior, particularly in the context of cyclical sectors. His assertion that volatility is a persistent feature of the market challenges the notion of stable investment periods.

NewsAI özeti

This article is for informational purposes only and does not constitute financial advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.